Podcasts
Podcast: Steve Mister on Regulatory Concerns, the Drug Exclusion Clause in DSHEA, and FTC Warnings on Health Claims
Podcast: Steve Mister on Regulatory Concerns, the Drug Exclusion Clause in DSHEA, and FTC Warnings on Health Claims
The Council for Responsible Nutrition's president and CEO also reflected on the association's 50th anniversary, its values, and priorities.
By Sean Moloughney, Editor04.28.23
Issues discussed in this podcast with Steve Mister, President & CEO of CRN include:
- The drug exclusion rule in DSHEA and the impact on CBD, NAC, NMN, and other ingredients;
- FDA restructuring of the Human Foods Program and industry’s relationship with its regulators;
- FDA’s “Dietary Supplement Ingredient Directory”;
- CBD and potential for a regulatory fix through the Farm Bill, or other legislative packages;
- FTC notices sent to companies about claims substantiation and its Health Products Compliance Guidance;
- Counterfeit products imitating dietary supplement brands and the potential impact on consumer trust;
- Results from a consumer survey and efforts to cover dietary supplement costs with HSAs and FSAs (Health Savings Accounts and Flexible Spending Accounts).
You can email us with feedback at nutraceuticals@rodmanmedia.com and subscribe to Mapping the Nutraceuticals World wherever you get your podcasts.
